
Alphanosos is a deep tech company focused on AI-driven innovation in healthcare and bio-industries. Since 2015, they have utilized proprietary generative AI algorithms to discover and develop supramolecular actives derived from edible plants. These actives are designed to be safe, effective, and patentable, with applications in technical, cosmetic, and therapeutic fields. Alphanosos aims to address 21st-century health and biotechnical challenges by combining cutting-edge AI with sustainable development principles, offering revolutionary solutions for human and animal health, as well as green solutions for bio-industries and agriculture. Their business model includes product licensing, R&D partnerships, and distributor-led product sales.

Alphanosos is a deep tech company focused on AI-driven innovation in healthcare and bio-industries. Since 2015, they have utilized proprietary generative AI algorithms to discover and develop supramolecular actives derived from edible plants. These actives are designed to be safe, effective, and patentable, with applications in technical, cosmetic, and therapeutic fields. Alphanosos aims to address 21st-century health and biotechnical challenges by combining cutting-edge AI with sustainable development principles, offering revolutionary solutions for human and animal health, as well as green solutions for bio-industries and agriculture. Their business model includes product licensing, R&D partnerships, and distributor-led product sales.